Microbial Risk Markers
Cross-source consensus on Microbial Risk Markers from 1 sources and 6 claims.
1 sources · 6 claims
Risks & contraindications
Where it comes from
Other
Other
Other
Highlighted claims
- The estrobolome consists of gut microbes capable of producing beta-glucuronidase. — Metagenomic Microbiome Analysis: Clinical Pearls and Diagnostic Patterns
- Elevated Ascomycota should first prompt clinicians to ask about Saccharomyces boulardii supplementation. — Metagenomic Microbiome Analysis: Clinical Pearls and Diagnostic Patterns
- Salmonella and Campylobacter findings indicate external contamination rather than normal gut microbiome membership. — Metagenomic Microbiome Analysis: Clinical Pearls and Diagnostic Patterns
- Fusobacterium nucleatum in the gut is presented as a major microbial risk factor for colorectal cancer. — Metagenomic Microbiome Analysis: Clinical Pearls and Diagnostic Patterns
- Elevated beta-glucuronidase activity is interpreted as evidence of hypertoxicity and stagnant detoxification pathways. — Metagenomic Microbiome Analysis: Clinical Pearls and Diagnostic Patterns
- Fusobacterium nucleatum in the gut usually reflects oral translocation and indicates a need to address digestive efficiency and oral-gut barrier integrity. — Metagenomic Microbiome Analysis: Clinical Pearls and Diagnostic Patterns